Cross-cultural development of an item list for computer-adaptive testing of fatigue in oncological patients

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Giesinger, Johannes M ^a   Aa Petersen, Morten ^b   Groenvold, Mogens ^b   Aaronson, Neil K ^c   Arraras, Juan I ^d   Conroy, Thierry ^e   Gamper, Eva M ^a   Kemmler, Georg ^a   King, Madeleine T ^f   Oberguggenberger, Anne S ^a   Velikova, Galina ^g   Young, Teresa ^h   Holzner, Bernhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b BISPEBJERG HOSPITAL   (Denmark)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d Instituto de Investigación Sanitaria de Navarra   (Spain)

^e CENTRE ALEXIS VAUTRIN   (France)

^f UNIVERSITY OF SYDNEY   (Australia)

^g UNIVERSITY OF LEEDS   (United Kingdom)

^h MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RELATED FATIGUE; COMPUTERIZED ADAPTIVE TESTING; CULTURAL ANTHROPOLOGY; FATIGUE; FATIGUE ASSESSMENT INSTRUMENT; FATIGUE SCALE; FUNCTIONAL ASSESSMENT; HUMAN; INTERVIEW; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SYSTEMATIC REVIEW; CLASSIFICATION; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; CULTURAL FACTOR; HOSPITALIZATION; INSTRUMENTATION; NEOPLASM; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; REPRODUCIBILITY; SICKNESS IMPACT PROFILE;

CROSS-CULTURAL COMPARISON; DIAGNOSIS, COMPUTER-ASSISTED; FATIGUE; HUMANS; NEOPLASMS; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 79953108199     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-19     Document Type: Article

References (55)

1. Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hemtol 1997, 34(Suppl2):13-19.
2. Vogelzang N, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997, 34(3/2):4-12.
3. Holzner B, et al. The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann Oncol 2002, 13(6):965-73. 10.1093/annonc/mdf122, 12123343.
4. Yellen SB, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. Journal of pain and symptom management 1997, 13(2):63-74. 10.1016/S0885-3924(96)00274-6, 9095563.
5. Holzner B, et al. Fatigue in ovarian carcinoma patients: a neglected issue?. Cancer 2003, 97(6):1564-72. 10.1002/cncr.11253, 12627522.
6. Radbruch L, et al. Fatigue in palliative care patients -- an EAPC approach. Palliat Med 2008, 22(1):13-32. 10.1177/0269216307085183, 18216074.
7. Glaus A, Crow R, Hammond S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Eur J Cancer Care (Engl) 1996, 5(2 Suppl):8-23. 10.1111/j.1365-2354.1996.tb00247.x, 9117043.
8. Cella D, et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001, 19(14):3385-3391.
9. Mock V. Fatigue management: evidence and guidelines for practice. Cancer 2001, 92(6 Suppl):1699-1707. 10.1002/1097-0142(20010915)92:6+<1699::AID-CNCR1500>3.0.CO;2-9, 11598890.
10. Minton O. Cancer-related fatigue. Eur J Cancer 2008, 44(8):1097-1104. 10.1016/j.ejca.2008.02.037, 18381237.
11. Lee K, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res 1991, 36(3):291-298. 10.1016/0165-1781(91)90027-M, 2062970.
12. Smets E, et al. The Multidimensional Fatigue Inventory (MFI) psychosomatic qualities of an instrument to assess fatigue. Journal of Psychosomatic Research 1995, 39:315-325. 10.1016/0022-3999(94)00125-O, 7636775.
13. Weis J, et al. EORTC Quality of Life module for the assessment of cancer related Fatigue (EORTC QLQ-FA13). 2010, [cited 2010 10th May]., http://groups.eortc.be/qol/qolg_projects.htm#fatigue
14. Piper BF, et al. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 1998, 25(4):677-84.
15. Mendoza TR, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999, 85(5):1186-96. 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N, 10091805.
16. Aaronson NK, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85(5):365-76. 10.1093/jnci/85.5.365, 8433390.
17. Cella DF, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993, 11(3):570-9.
18. Lai J-S, et al. An item bank was created to improve the measurement of cancer-related fatigue. J Clin Epidemiol 2005, 58(2):190-7. 10.1016/j.jclinepi.2003.07.016, 15680754.
19. Lai J-S, Crane Paul K, Cella D. Factor analysis techniques for assessing sufficient unidimensionality of cancer related fatigue. Qual Life Res 2006, 15(7):1179-90. 10.1007/s11136-006-0060-6, 17001438.
20. Cella D, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care 2007, 45(5 Suppl 1):S3-S11. 10.1097/01.mlr.0000258615.42478.55, 2829758, 17443116.
21. The PROMIS network Patient-Reported Outcomes Measurement Information System (PROMIS). 2010, [cited 2010 25 May 2010], The PROMIS network., http://www.nihpromis.org/default.aspx
22. Petersen MA, et al. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning. Eur J Cancer 2010, 46(8):1352-8. 10.1016/j.ejca.2010.02.011, 20231085.
23. Petersen MA, et al. Development of computerized adaptive testing (CAT) for the EORTC QLQ-C30 physical functioning dimension. Qual Life Res 2010,
24. Dewolf L, et al. EORTC Quality of Life Group Translation Procedure. 2009, Brussels: EORTC, 3.
25. Blazeby J, et al. Guidelines for Developing Questionnaire Modules. 2002, Brussels: EORTC Quality of Life Group.
26. Reise SP, Waller NG. Item response theory and clinical measurement. Annu Rev Clin Psychol 2009, 5:27-48. 10.1146/annurev.clinpsy.032408.153553, 18976138.
27. Fries JF, et al. Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol 2009, 36(9):2061-6. 10.3899/jrheum.090358, 19738214.
28. Chalder T, et al. Development of a fatigue scale. J Psychosom Res 1993, 37(2):147-53. 10.1016/0022-3999(93)90081-P, 8463991.
29. Okuyama T, et al. Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer 2000, 8(3):215-22. 10.1007/s005200050288, 10789963.
30. Holley SK. Evaluating patient distress from cancer-related fatigue: an instrument development study. Oncol Nurs Forum 2000, 27(9):1425-31.
31. Tiesinga LJ, Dassen TW, Halfens RJ. DUFS and DEFS: development, reliability and validity of the Dutch Fatigue Scale and the Dutch Exertion Fatigue Scale. Int J Nurs Stud 1998, 35(1-2):115-23. 10.1016/S0020-7489(98)00005-4, 9695018.
32. Fisk JD, Doble SE. Construction and validation of a fatigue impact scale for daily administration (D-FIS). Qual Life Res 2002, 11(3):263-72. 10.1023/A:1015295106602, 12074263.
33. Velikova G, et al. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. Eur J Cancer 2007, 43(1):87-94. 10.1016/j.ejca.2006.09.004, 17081744.
34. Cocks K, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer 2007, 43(11):1670-8. 10.1016/j.ejca.2007.04.022, 17574838.
35. Greimel E, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer 2003, 39(10):1402-8. 10.1016/S0959-8049(03)00307-1, 12826043.
36. Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res 1993, 37(7):753-62. 10.1016/0022-3999(93)90104-N, 8229906.
37. Glaus A, Muller S. [Measuring fatigue of cancer patients in the German-speaking region: development of the Fatigue Assessment Questionnaire]. Pflege 2001, 14(3):161-70. 10.1024/1012-5302.14.3.161, 12385268.
38. Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale. J Psychosom Res 2003, 54(4):345-52. 10.1016/S0022-3999(02)00392-6, 12670612.
39. Iriarte J, Katsamakis G, de C. The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis. Mult Scler 1999, 5(1):10-6.
40. Fisk JD, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994, 18(Suppl 1):S79-83. 10.1093/clinids/18.Supplement_1.S79, 8148458.
41. Yoshitake H. Three caracteristic patterns of subjective fatigue symptoms. Ergonomics 1978, 21(3):231-3. 10.1080/00140137808931718, 27351.
42. Hann DM, et al. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res 1998, 7(4):301-10. 10.1023/A:1008842517972, 9610214.
43. Krupp LB, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46(10):1121-3.
44. Hartz A, Bentler S, Watson D. Measuring fatigue severity in primary care patients. J Psychosom Res 2003, 54(6):515-21. 10.1016/S0022-3999(02)00600-1, 12781305.
45. Belza BL. Comparison of self-reported fatigue in rheumatoid arthritis and controls. J Rheumatol 1995, 22(4):639-43.
46. Kos D, et al. Evaluation of the Modified Fatigue Impact Scale in four different European countries. Mult Scler 2005, 11(1):76-80. 10.1191/1352458505ms1117oa, 15732270.
47. Stein KD, et al. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 1998, 6(3):143-52. 10.1046/j.1523-5394.1998.006003143.x, 9652245.
48. Stein KD, et al. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage 2004, 27(1):14-23. 10.1016/j.jpainsymman.2003.06.003, 2547485, 14711465.
49. Piper BF. Piper fatigue scale available for clinical testing. Oncol Nurs Forum 1990, 17(5):661-2.
50. Schwartz AL. The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol Nurs Forum 1998, 25(4):711-7.
51. Yang CM, Wu CH. The situational fatigue scale: a different approach to measuring fatigue. Qual Life Res 2005, 14(5):1357-62. 10.1007/s11136-004-5680-0, 16047510.
52. Hadzi-Pavlovic D, et al. Screening for prolonged fatigue syndromes: validation of the SOFA scale. Soc Psychiatry Psychiatr Epidemiol 2000, 35(10):471-9. 10.1007/s001270050266, 11127722.
53. Ahsberg E, Gamberale F, Gustafsson K. Perceived fatigue after mental work: an experimental evaluation of a fatigue inventory. Ergonomics 2000, 43(2):252-68. 10.1080/001401300184594, 10675062.
54. Wu HS, Wyrwich KW, McSweeney M. Assessing fatigue in persons with cancer: further validation of the Wu Cancer Fatigue Scale. J Pain Symptom Manage 2006, 32(3):255-65. 10.1016/j.jpainsymman.2006.06.001, 16939850.
55. Flachenecker P, et al. Validierung des Würzburger Erschöpfungsinventars bei Multipler Sklerose (WEIMuS). Neurologie & Rehabilitation 2008, 14(6):299-306.